| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/24/1997 | WO1997014800A1 Novel saliva binding protein |
| 04/24/1997 | WO1997014799A1 Fibronectic binding protein b compounds |
| 04/24/1997 | WO1997014797A2 Cystatin m, a novel cysteine proteinase inhibitor |
| 04/24/1997 | WO1997014796A1 Monoclonal antibody br110 and uses thereof |
| 04/24/1997 | WO1997014795A1 Tumor associated polypeptides with carboxyl-terminal alanine-proline, proline-proline or glycine-proline and antibodies thereto |
| 04/24/1997 | WO1997014794A1 ACTIVATION OF p53 PROTEIN |
| 04/24/1997 | WO1997014792A2 Oligonucleotides with anti-respiratory syncytial virus activity |
| 04/24/1997 | WO1997014790A1 Cloning of vertebrate pheromone receptors and uses thereof |
| 04/24/1997 | WO1997014716A1 Cyclopeptide derivatives |
| 04/24/1997 | WO1997014715A1 Receptor-selective somatostatin analogs |
| 04/24/1997 | WO1997014714A1 The aiolos gene |
| 04/24/1997 | WO1997014713A1 Amphiphilic complexes, method for preparing same and compositions containing such complexes |
| 04/24/1997 | WO1997014709A1 Antisense oligomers |
| 04/24/1997 | WO1997014441A1 Method for restoring glucose responsiveness to insulin secretion |
| 04/24/1997 | WO1997014440A1 Conjugation of c-myc antisense oligonucleotides with cholesterol to significantly enhance their inhibitory effect on neointimal hyperplasia |
| 04/24/1997 | WO1997014437A1 Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling |
| 04/24/1997 | WO1997014436A1 Synthetic vaccine for protection against human immunodeficiency virus infection |
| 04/24/1997 | WO1997014433A1 Chicken interleukin-15 and uses thereof |
| 04/24/1997 | WO1997014432A1 Modulation of integrin-mediated signal transduction |
| 04/24/1997 | WO1997014430A1 Use of thioethers as antioxidant for peptides and proteins and compositions containing the thioethers |
| 04/24/1997 | WO1997014429A1 Stable pharmaceutical forms of administration containing parathormone |
| 04/24/1997 | WO1997014428A1 Use of human chorionic gonadotropin in the treatment of kaposi's sarcoma |
| 04/24/1997 | WO1997014427A1 USE OF PROTEIN S-100b IN MEDICINES AND MEDICINES CONTAINING THE PROTEIN S-100b |
| 04/24/1997 | WO1997014426A1 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 04/24/1997 | WO1997014425A1 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii |
| 04/24/1997 | WO1997014424A1 Neurological drug screens |
| 04/24/1997 | WO1997014416A1 Conjugates useful in the treatment of benign prostatic hyperplasia |
| 04/24/1997 | WO1997014408A1 Sustained release particles |
| 04/24/1997 | WO1997014407A1 Insoluble drug delivery |
| 04/24/1997 | WO1997014307A1 Method for treating ischemic tissue |
| 04/24/1997 | WO1997014290A1 Synthesis of immunologic, therapeutic and prophylactic compounds by endophytic microorganisms |
| 04/24/1997 | WO1997011968A3 A gene associated with liver neoplastic disease |
| 04/24/1997 | WO1997011669A3 MHC-class II restricted melanoma antigens and their use in therapeutic methods |
| 04/24/1997 | WO1997009348A3 Orphan receptor |
| 04/24/1997 | WO1997008934A3 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 04/24/1997 | WO1997007784A3 LIPOSOMAL PHOSPHODIESTER, PHOSPHOROTHIOATE, AND p-ETHOXY OLIGONUCLEOTIDES |
| 04/24/1997 | WO1997006258A3 CDNA sequence, amino-acid sequence, derived from the CDNA sequence, of the precursor protein of human GCAP-II/uroguanyline, and amino-acid sequence of the fragment circulating in human blood |
| 04/24/1997 | WO1997005267A3 Mucosal delivery of polynucleotides |
| 04/24/1997 | WO1996034107A3 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/24/1997 | DE19540487A1 Cell interaction system for induction of artificial 3-dimensional tissue |
| 04/24/1997 | DE19538741A1 Cyclopeptidderivate Cyclopeptide derivatives |
| 04/24/1997 | DE19538687A1 Stabile pharmazeutische Darreichungsformen enthaltend Parathormon The stable pharmaceutical dosage forms containing parathyroid hormone |
| 04/24/1997 | CA2241835A1 Conjugation of c-myc antisense oligonucleotides with cholesterol to significantly enhance their inhibitory effect on neointimal hyperplasia |
| 04/24/1997 | CA2235278A1 Use of protein s-100b in medicines and medicines containing the protein s-100b |
| 04/24/1997 | CA2235168A1 Synthetic vaccine for protection against human immunodeficiency virus infection |
| 04/24/1997 | CA2234884A1 Receptor-selective somatostatin analogs |
| 04/24/1997 | CA2234877A1 Herpesvirus vectors and their uses |
| 04/24/1997 | CA2234724A1 Stable pharmaceutical forms of administration containing parathyroid hormone |
| 04/24/1997 | CA2234708A1 Animals with targeted gene deletion |
| 04/24/1997 | CA2234090A1 Method of activating a novel ligand regulatory pathway |
| 04/24/1997 | CA2233848A1 Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling |
| 04/24/1997 | CA2233549A1 Method for restoring glucose responsiveness to insulin secretion |
| 04/24/1997 | CA2207973A1 Modulation of integrin-mediated signal transduction |
| 04/23/1997 | EP0769554A2 Human CNP gene and precursor protein |
| 04/23/1997 | EP0769552A1 Antisense nucleic acid compound |
| 04/23/1997 | EP0769147A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 04/23/1997 | EP0769146A2 Screening for nuc inhibitors |
| 04/23/1997 | EP0769060A1 Fas associated proteins |
| 04/23/1997 | EP0769059A1 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 04/23/1997 | EP0769056A1 NON-SPLICING VARIANTS OF gp350/220 |
| 04/23/1997 | EP0769055A1 Variants of leukemia inhibitory factor |
| 04/23/1997 | EP0769054A1 Immunomodulators |
| 04/23/1997 | EP0769053A2 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma |
| 04/23/1997 | EP0769050A1 Unglycosylated plasminogen activator-derivative and its use with increased risks of bleeding |
| 04/23/1997 | EP0769025A1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
| 04/23/1997 | EP0769024A1 High-affinity melatonin receptors and uses thereof |
| 04/23/1997 | EP0769023A1 Retinoic acid receptor epsilon |
| 04/23/1997 | EP0769022A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions |
| 04/23/1997 | EP0769021A2 Transgenic fish in the treatment of diabetes |
| 04/23/1997 | EP0769020A1 NEW hIL-4 MUTANT PROTEINS USED AS ANTAGONISTS OR PARTIAL AGONISTS OF HUMAN INTERLEUKIN 4 |
| 04/23/1997 | EP0769019A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 04/23/1997 | EP0769018A1 Helicobacter proteins and vaccines |
| 04/23/1997 | EP0769006A1 Small molecule inhibitors of rotamase enzyme activity |
| 04/23/1997 | EP0768898A1 Cascade-polymer complexes and methods of producing the same |
| 04/23/1997 | EP0768894A1 Multi-stage cascade boosting vaccine |
| 04/23/1997 | EP0768892A1 Thrombolytic composition |
| 04/23/1997 | EP0768891A1 Use of insulin and igf-i |
| 04/23/1997 | EP0768890A1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 04/23/1997 | EP0768889A1 Cancer therapy using lymphotoxin |
| 04/23/1997 | EP0768888A1 Use of muramyl peptide compounds |
| 04/23/1997 | EP0768869A1 Factor to grow tissue ex vivo |
| 04/23/1997 | EP0768866A1 Desquamation compositions |
| 04/23/1997 | EP0768821A1 pp60PIK : A DOWNSTREAM ELEMENT IN INSULIN SIGNALING |
| 04/23/1997 | EP0768819A1 Combined virustatic antimediator (covam) treatment of common colds |
| 04/23/1997 | EP0749472A4 Extracorporeal cell culture and transplantation kits |
| 04/23/1997 | EP0703776B1 Utilization of a peptide having a lysin group and an alanine group in the terminal position for the preparation of a depigmenting composition, and depigmenting composition thus obtained |
| 04/23/1997 | EP0655927B1 Interleukin-4 stimulated t lymphocyte cell death |
| 04/23/1997 | EP0651754B1 K-252a DERIVATIVES |
| 04/23/1997 | EP0626942B1 Bicyclo[2.2.2.]octane derivatives as cholestocystokinin inhibitors |
| 04/23/1997 | EP0624196B1 Polypeptides with fibronectin binding sites as modulators for matrix assembly |
| 04/23/1997 | EP0621869B1 Human kunitz-type protease inhibitor variants |
| 04/23/1997 | EP0594592B1 A growth factor in connection with artificial transplants |
| 04/23/1997 | EP0513316B1 Analytical tracers for cancer, particularly malignant breast cancer |
| 04/23/1997 | EP0495049B1 Process for the enzymatic preparation of basic fibroblast growth factor |
| 04/23/1997 | EP0493418B1 Method of producing fusion proteins |
| 04/23/1997 | EP0400047B1 Modified hepatocytes and uses therefor |
| 04/23/1997 | EP0394418B1 Osteogenic factors |
| 04/23/1997 | CN1148408A Hematopoietic Protein and materials and method for making it |
| 04/23/1997 | CN1148394A Prostaglandin E receptor |
| 04/23/1997 | CN1148393A Bradykinin antagonist peptides incorporating N-substituted glycines |